Manufacturer record

Trimedix Pharma (P) Ltd. C-40: regulatory record

Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories

2 batches manufactured by Trimedix Pharma (P) Ltd. C-40 (Punjab) were declared Not of Standard Quality in December 2025. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.

Most recent flagged batch: TS-538, Levosalbutamol, Ambroxol Hydrochloride & Guaiphenesin Syrup STUQOF-LS (exp Jun 2027). RDTL, Chandigarh (CDSCO lab) found it not of standard quality: The sample does not conform to claim as per Patent and Proprietary in respect to The Assay of Levosalbutamol Sulphate calculated as. Listed in the December 2025 alert.

Records by type

2 records linked to Trimedix Pharma (P) Ltd. C-40 in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.

0Banned or prohibited
0Recalled or suspended
2Failed a lab test
0Regulatory notice
Primary government sourceTier 1: government primary source

CDSCO drug alerts: Not of Standard Quality and spurious drugs

CDSCO · CDSCO monthly NSQ alerts, Dec 2025 to Dec 2025

View original document

Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.

2
NSQ batches since 2025
2
Products affected
Assay
Most common failure
Dec 2025
Latest alert

Flagged batches per year

2025 · 2

All flagged batches

Product Batch Reason declared NSQ Tested by Alert
Levosalbutamol, Ambroxol Hydrochloride & Guaiphenesin Syrup STUQOF-LS Batch TS-538Mfg Jul 2025 · Exp Jun 2027 The sample does not conform to claim as per Patent and Proprietary in respect to The Assay of Levosalbutamol Sulphate calculated as LevosalbutamolAssay RDTL, ChandigarhCDSCO lab Dec 2025
Levosalbutamol, Ambroxol Hydrochloride & Guaiphenesin Syrup AMBROX-LG Batch TS-249Mfg Apr 2025 · Exp Mar 2027 The sample does not conform to claim as per Patent and Proprietary in respect to The Assay of Levosalbutamol Sulphate calculated as LevosalbutamolAssay RDTL, ChandigarhCDSCO lab Dec 2025

Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.